The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers
暂无分享,去创建一个
M. Sand | I. Jang | Viktoria Moschetti | H. Rosenbrock | W. Timmer | K. Boland | U. Feifel | G. Andersen | Maria Kim | Glen Wunderlich | V. Moschetti